- Home
- IPI vs ATAI Comparison
IPI vs ATAI Comparison
Compare IPI & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPI
- ATAI
- Stock Information
- Founded
- IPI 2000
- ATAI 2018
- Country
- IPI United States
- ATAI Germany
- Employees
- IPI N/A
- ATAI N/A
- Industry
- IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- IPI Industrials
- ATAI Health Care
- Exchange
- IPI Nasdaq
- ATAI Nasdaq
- Market Cap
- IPI 470.9M
- ATAI 444.7M
- IPO Year
- IPI 2008
- ATAI 2021
- Fundamental
- Price
- IPI $28.64
- ATAI $4.13
- Analyst Decision
- IPI Strong Sell
- ATAI Strong Buy
- Analyst Count
- IPI 1
- ATAI 3
- Target Price
- IPI $23.00
- ATAI $13.33
- AVG Volume (30 Days)
- IPI 150.6K
- ATAI 7.1M
- Earning Date
- IPI 08-06-2025
- ATAI 08-15-2025
- Dividend Yield
- IPI N/A
- ATAI N/A
- EPS Growth
- IPI N/A
- ATAI N/A
- EPS
- IPI N/A
- ATAI N/A
- Revenue
- IPI $225,166,000.00
- ATAI $1,863,000.00
- Revenue This Year
- IPI $11.06
- ATAI $423.05
- Revenue Next Year
- IPI $0.74
- ATAI N/A
- P/E Ratio
- IPI N/A
- ATAI N/A
- Revenue Growth
- IPI 10.53
- ATAI 572.56
- 52 Week Low
- IPI $20.86
- ATAI $1.03
- 52 Week High
- IPI $39.01
- ATAI $4.40
- Technical
- Relative Strength Index (RSI)
- IPI 25.97
- ATAI 69.30
- Support Level
- IPI $31.50
- ATAI $3.78
- Resistance Level
- IPI $33.38
- ATAI $4.25
- Average True Range (ATR)
- IPI 1.81
- ATAI 0.34
- MACD
- IPI -0.59
- ATAI 0.03
- Stochastic Oscillator
- IPI 6.82
- ATAI 79.85
About IPI Intrepid Potash Inc
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.